Showing 2071-2080 of 3637 results for "".
Type Casting: Assessing Personality Before a Hire
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/type-casting-assessing-personality-before-a-hire/22994/Can the Myers–Briggs Type Indicator take the guess work out of your next hiring decision?Take 5: Clinically-Relevant Findings About Causes and Treatment of Rosacea
https://practicaldermatology.com/columns/take-5/take-5-clinically-relevant-findings-about-causes-and-treatment-of-rosacea/21870/Research sheds light on the pathogenesis of the disease and patients' experience.Therapeutics Update: New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/therapeutics-update-new-products-and-pharmacologic-developments/20831/Protect Your Data. Protect Yourself
https://practicaldermatology.com/topics/practice-management/protect-your-data-protect-yourself/22906/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21616/New products and pharmacologic developmentsTake 5: Promising Therapies for Rosacea
https://practicaldermatology.com/columns/take-5/take-5-promising-therapies-for-rosacea/21716/Five new studies offer insights for treating and understanding rosacea.Take 5: Innovations in Aesthetic Treatments
https://practicaldermatology.com/columns/take-5/take-5-innovations-in-aesthetic-treatments/21746/Five new or emerging products may expand skin rejuvenation options.Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
https://practicaldermatology.com/programs/cme/data-driving-recent-guideline-updates-in-neoadjuvant-therapy-for-resectable-melanoma/36322/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
https://practicaldermatology.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-braf-mutant-stage-iv-melanoma/36328/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://practicaldermatology.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.